Back

The association between SGLT2 inhibitors and new-onset osteoporosis in patients with type 2 diabetes: a population-based longitudinal cohort study

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart: pharmacotherapy (1) Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Chih-Feng Chang

Taichung (Taiwan)

6 More presentations in this session

Presentation thumbnail
Efficacy of Semaglutide in glycemic control, weight loss, and improving lipid profile- the role of baseline vitamin D levels.
Professor R. Abo Fanne (Hadera, IL)
Abstract Slides Video
Presentation thumbnail
Statin therapy for primary prevention of microvascular complications in patients with heart failure and type 2 diabetes: a target trial emulation
Miss A. Matsumoto (HK)
Abstract Slides Video
Presentation thumbnail
Parallel disease trajectories of peripheral neurovascular disease and heart failure in type 2 diabetes mellitus: a 12-year prospective follow-up
Doctor D. Andric (Novi Sad, RS)
Abstract Slides Video
Presentation thumbnail
Suboptimal cardioprotective medication prescribing in patients with diabetes and stage B heart failure
Mr M. Hussain (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Effects of semaglutide and dapagliflozin on natriuretic peptides in type 2 diabetes: a randomized comparative study
Doctor C. Lejonberg (Helsingborg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart: pharmacotherapy (1)

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes patients: a propensity score-matched study
27 August 2022
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors on temporal change of skeletal muscle index in patients with outpatient cardiac rehabilitation program
3 April 2025
thumbnail
Congress Presentation
Incident use of loop diuretics and incident heart failure in type-2 diabetes mellitus: a precision medicine approach
1 September 2025
thumbnail
Congress Presentation
Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database
3 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources